Jump to content
Knowledge Hub

News Archive

Public Consultation - Declaration of Helsinki

8th February 2024

Phase I period for public consultation now open.

Read More+

EMA - EMA to support establishment of the African Medicines Agency

7th February 2024

EMA will harness its unique experience in coordinating intra-regional medicines regulation to support the strengthening of the African regulatory network. EMA has received a grant of ten million euros from the European Commission to support regulatory systems at national and regional level in Africa, and in particular for the setting up of the African Medicines Agency (AMA), in collaboration with African, European and international actors.

Read More+

EMA - New platform for collection of sales and use data of antimicrobials in animals

7th February 2024

EMA has just launched the new Antimicrobial Sales and Use (ASU) Platform to support the collection of data by Member States on the sales and use of antimicrobials in animals.

Read More+

EMA - Transition to the Clinical Trials Information System (CTIS) by 31 January 2025

7th February 2024

All ongoing clinical trials in the EU must be transitioned to the Clinical Trials Information System (CTIS) by 31 January 2025.

Read More+

EMA - Veterinary medicines: Highlights of 2023

7th February 2024

On 24 January 2024 EMA published an overview of its key recommendations of 2023 regarding the authorisation and safety monitoring of veterinary medicines.

Read More+

FDA - GMP for APIs Used in Veterinary Medicinal Products

7th February 2024

CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products Draft released and open for comments.

Read More+

FDA - Roundup, 6th February 2024

7th February 2024

An at-a-glance summary of news from around the agency

Read More+

MHRA - updates on to how to notify the MHRA of changes to the PV System

7th February 2024

Guidance updates on to how to notify the MHRA of changes to the PV System

Read More+

Union Health Ministry (India) notified revised rules under Schedule M of the Drugs and Cosmetics Rules, 1945

7th February 2024

The revised Schedule M prescribes the Good Manufacturing Practices (GMP) and requirements of premises, plant, and equipment for pharmaceutical products; official says this will ensure Indian guidelines are at par with global standards.

Read More+

EMA - New Q&As on EU GMP Guide Annexe

2nd February 2024

Annex 1: Manufacture of sterile medicinal products

Read More+
« Previous | Page 44 of 128 | Next »

Share